Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home Search
diabetes - search results
If you're not happy with the results, please do another search
Metabolic diseases and the brain: Obesity, type 2 diabetes and neurofibrosis
Garron Dodd, Head of the Metabolic Neuroscience Laboratory at The University of Melbourne, Australia and Founder, Chief Scientific Officer of Gallant Bio, investigates the brain ‘goo’ behind obesity and type-2 diabetes - and how we can treat it.
Francesc Xavier Cos Claramunt, MD PhD Msc – Primary Care Diabetes Europe
Innovation and research officer at Institut Català de la Salut.
Associate Professor Universitat Autonoma de Barcelona
Member of CIBERDEM
Chairman Primary Care Diabetes Europe
Dr Francesc Xavier Cos is a general practitioner and member of the innovation and research support team at Institut Català de la Salut in Spain. His main interests include...
Adult-onset type 1 diabetes increases the risk of cardiovascular disease
A new study reveals that adults diagnosed with type 1 diabetes face a heightened risk of cardiovascular disease and death, with no better prognosis than those diagnosed in childhood.
An unexpected role for the brain in blood glucose control and diabetes
Reactions were mixed some 14 years ago, when we and others first reported that in rodent models of type 1 diabetes (T1D), metabolic derangements resulting from severe insulin deficiency could be fully reversed by infusing the adipocyte (fat cell) hormone leptin directly into the brain.
Targeting the brain for the treatment of type 1 diabetes
Michael W. Schwartz, MD, explains the role played by the brain as a cause of elevated blood sugar and related metabolic derangements in type 1 diabetes, and how therapeutic targeting of this brain system can eliminate the need for insulin therapy in animal models.
One in nine people is living with diabetes, finds IDF research
New research from the International Diabetes Federation (IDF) has revealed that one in nine adults is living with diabetes.
The UW Medicine Diabetes Institute (UWMDI)
The UW Medicine Diabetes Institute (UWMDI) is the first of its kind in the Pacific Northwest, integrating state-of-the-art research programs with superb care for patients with diabetes, obesity and their complications.
Michael W. Schwartz, MD – UW Medicine Diabetes Institute
After graduating from Rush Medical College in 1983 and completing his medical residency at the University of Washington (UW) in 1986, Dr. Schwartz remained at UW for his specialty training in endocrinology and metabolism. In 1993, he joined the full-time faculty at UW, rising to the rank of full...
AI in diabetes care – Paving the way for a new era of healthcare
Afon Technology is a leader in advanced medical technology focused on transforming diabetes care. Brad Love and Dan Fowles discuss how the company uses big data to create personalised health solutions that can significantly impact the lives of millions.
Preventing sight loss for people with diabetes with new advanced eye scans
Providing advanced eye scans to people with diabetes could help in preventing sight loss for thousands whilst also freeing up NHS appointments.
MMPC-live: Accessible resources for phenotyping of live mouse models of diabetes and obesity
Professor Carol F. Elias, from the University of Michigan’s Department of Molecular & Integrative Physiology, discusses key research opportunities enabled by the NIDDK Mouse Metabolic Phenotyping Center in live models – MMPC-Live.
World diabetes day 2024: Understanding obesity and diabetes
On World Diabetes Day, we explore the links between stress hormones and diabetes and what this could mean for future treatments.
The importance of foot care for people with diabetes
Regular foot check-ups are critical for mitigating foot problems in people with diabetes; Lorna Rothery spoke to the podiatry team at Mid Yorkshire Teaching Hospital about the risk factors for and prevention of diabetic foot problems.
Why more attention is needed on adult-onset type 1 diabetes
Dr Rayaz A Malik, Professor of Medicine at Weill Cornell Medicine-Qatar, discusses the challenges and impact of misdiagnosis and late diagnosis in type 1 diabetes.
New study links heme iron from red meat to higher risk of type 2...
What is the relationship between dietary iron intake and the risk of developing type 2 diabetes (T2D)?
A study led by researchers at Harvard T.H. Chan School of Public Health, analysed data spanning 36 years from over 200,000 adults enrolled in the Nurses' Health Studies I and II and the...
Non-invasive blood glucose sensor will transform diabetes care
Sabih Chaudhry, CEO of Afon Technology Ltd, describes the company’s innovative Glucowear™ — the world’s first non-invasive, real-time, and continuous blood glucose sensor.
The role of education in tackling diabetes stigma
Beyond the impact of the COVID-19 pandemic on routine care, other factors impact the physical and mental wellbeing of people with diabetes. Lorna Rothery spoke to Dr Mayank Patel, a consultant in diabetes at University Hospital Southampton and member of the DRWF editorial advisory board, about the importance of education in changing attitudes towards type 1 and type 2 diabetes stigma.
Meal replacements: An educational tool for weight reduction in patients with diabetes in rural...
Richard J Santen, Emeritus Professor of Medicine at the University of Virginia, discusses how meal replacements can aid successful weight loss for individuals with diabetes living in rural, underserved communities.
How well do Type 2 diabetes patients know their disease?
Researchers in Portugal look at the critical gaps in knowledge against type 2 diabetes (T2D) patients, potentially impacting their long-term health outcomes.
Key resource for underserved patients with diabetes in the USA
The FQHCs handle 114.2 million patient visits per year. In 2021, one of 4 of these visits was virtual and involved the use of telemedicine, here we explore the value of telemedicine for diabetes patients in rural areas of America
Patients with diabetes mellitus living in rural, underserved areas have...
